At the time of writing, Compass Therapeutics Inc [CMPX] stock is trading at $1.84, up 0.55%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CMPX shares have gain 12.20% over the last week, with a monthly amount glided 14.29%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Compass Therapeutics Inc [NASDAQ: CMPX] stock has seen the most recent analyst activity on September 16, 2024, when Ladenburg Thalmann upgraded its rating to a Buy but kept the price target unchanged to $5 for it. Previously, Jefferies started tracking the stock with Buy rating on January 31, 2023, and set its price target to $8. On January 27, 2023, Stifel initiated with a Buy rating and assigned a price target of $9 on the stock. Ladenburg Thalmann initiated its recommendation with a Buy and recommended $7 as its price target on March 15, 2022. B. Riley Securities started tracking with a Buy rating for this stock on January 19, 2022, and assigned it a price target of $10. In a note dated December 22, 2021, Raymond James initiated an Outperform rating and provided a target price of $5 on this stock.
For the past year, the stock price of Compass Therapeutics Inc fluctuated between $0.76 and $2.34. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Compass Therapeutics Inc [NASDAQ: CMPX] shares were valued at $1.84 at the most recent close of the market. An investor can expect a potential return of 171.74% based on the average CMPX price forecast.
Analyzing the CMPX fundamentals
Gross Profit Margin for this corporation currently stands at 0.34% with Operating Profit Margin at -18.79%, Pretax Profit Margin comes in at -15.98%, and Net Profit Margin reading is -15.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.29 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.7500 points at the first support level, and at 1.6600 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9200, and for the 2nd resistance point, it is at 2.0000.
Ratios To Look Out For
It is important to note that Compass Therapeutics Inc [NASDAQ:CMPX] has a current ratio of 16.15. As well, the Quick Ratio is 16.15, while the Cash Ratio is 6.08. Considering the valuation of this stock, the price to sales ratio is 297.84, the price to book ratio is 1.73.
